Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Leriglitazone
Placebo
Locations
13
United States
Stanford University Medical Center
Palo Alto, California, United States
Neuro Medicine Hospital / UF Health
Gainesville, Florida, United States
Kennedy Krieger Institute
Baltimore, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Minnesota
Minneota, Minnesota, United States
Health University of Utah
Salt Lake City, Utah, United States
Start Date
July 12, 2023
Primary Completion Date
May 1, 2027
Completion Date
May 1, 2027
Last Updated
November 17, 2025
NCT02698579
NCT01896102
Lead Sponsor
Minoryx Therapeutics, S.L.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions